These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 9228463

  • 21. Inhibition of the kallikrein-kinin system and vascular reactivity in Bartter's syndrome.
    Rodriguez-Portales JA, Lopez-Moreno JM, Mahana D.
    Hypertension; 1985; 7(6 Pt 1):1017-22. PubMed ID: 2416684
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Plasma-aldosterone and renin activity in Bartter's syndrome (author's transl)].
    Rössler R.
    Dtsch Med Wochenschr; 1975 Nov 21; 100(47):2443-8. PubMed ID: 171132
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Bartter's syndrome--treatment with potassium, spironolactone and ACE-inhibitor.
    Clementsen P, Høegholm A, Hansen CL, Damkjaer M, Christensen P, Giese J.
    J Intern Med; 1989 Feb 21; 225(2):107-10. PubMed ID: 2646391
    [Abstract] [Full Text] [Related]

  • 27. Reversal of altered vascular responsiveness in Bartter's syndrome by indomethacin treatment.
    Shimoyama R.
    J Clin Endocrinol Metab; 1980 Oct 21; 51(4):908-11. PubMed ID: 6999001
    [Abstract] [Full Text] [Related]

  • 28. Long-term use of propranolol, ibuprofen, and spironolactone in the management of Bartter's syndrome.
    Cunningham RJ, Brouhard BH, Berger M, Petrusick T, Travis LB.
    Pediatrics; 1979 May 21; 63(5):754-6. PubMed ID: 440896
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Quantitative and qualitative estimation of urinary kallikrein in a patient with Bartter's syndrome.
    Yamada K, Watanabe M, Nishikawa T, Mikami K, Shirai K, Tamura Y, Yamamoto M, Kumagai A, Matsuda Y, Moriya H.
    Endocrinol Jpn; 1978 Dec 21; 25(6):583-9. PubMed ID: 751804
    [Abstract] [Full Text] [Related]

  • 33. Indomethacin in Bartter's syndrome: does the syndrome represent a state of hyperprostaglandinism?
    Donker AJ, de Jong PE, van Eps LW, Brentjens JR, Bakker K, Doorenbos H.
    Nephron; 1977 Dec 21; 19(4):200-13. PubMed ID: 917167
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Bartter's syndrome presenting with features resembling renal tubular acidosis. Improvement of renal tubular defects by indomethacin.
    Rodriguez-Soriano J, Vallo A, Oliveros R.
    Helv Paediatr Acta; 1978 Jun 21; 33(2):141-51. PubMed ID: 659258
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Bartter's syndrome. Current prospects of nosographic classification and new therapeutic possibilities].
    Cordone G, Fasce L, Gianfranceschi P, Delucchi M, Iester A, Torcia R.
    Minerva Pediatr; 1978 Jul 15; 30(13):1097-104. PubMed ID: 672851
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Treatment of Bartter's syndrome with indomethacin.
    Garin EH, Fennell RS, Iravani A, Richard GA.
    Am J Dis Child; 1980 Mar 15; 134(3):258-61. PubMed ID: 6767392
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.